Celleration
成立一年
1999階段
收購了 |收購總了
73.85美元估值
0000美元缺失:Celleration的產品演示和案例研究
向技術買家推銷你的產品。
接觸1000個買家,他們使用CB Insights來識別供應188bet游戏商,演示產品,並做出購買決定。
缺失:Celleration的產品和差異化
不要讓你的產品被跳過。買家使用我們的供應商排名來篩選公司,並推動提案請求(rfp)。
專家收藏包含Celleration
專家收藏是由分析師策劃的列表,突出了你在最重要的技術領域需要了解的公司。
包括Celleration2專家收藏,包括醫療設備.
醫療設備
11702件
開發醫療設備的公司(根據IMDRF對“醫療設備”的定義)。包括軟件、實驗室開發的測試(LDTs)和組合產品。*盡可能定期更新列。
它的健康
7901件
Celleration專利
Celleration已申請8項專利。
申請日 |
授予日期 |
標題 |
相關的話題 |
狀態 |
---|---|---|---|---|
11/18/2014 |
1/18/2022 |
采購產品超聲,醫療超聲檢查,醫療治療,聲學,醫療設備 |
格蘭特 |
申請日 |
11/18/2014 |
---|---|
授予日期 |
1/18/2022 |
標題 |
|
相關的話題 |
采購產品超聲,醫療超聲檢查,醫療治療,聲學,醫療設備 |
狀態 |
格蘭特 |
最新的Celleration新聞
2016年12月22日
主頁»主題»醫療設備»最新消息»Celleration, Inc.醫療設備交易和聯盟簡介價格從250美元起Celleration是Alliqua BioMedical, Inc.的子公司,是一家商業化和開發治療性超聲平台的醫療設備公司。該公司為傷口護理市場提供醫療產品。它的MIST療法是非接觸的,無痛的,低頻超聲通過鹽水霧傳送到傷口床。Celleration的療法產生超聲波,產生並向傷口輸送無菌生理鹽水。其MIST療法取代了運動醫學、胎兒監測和物理治療的耦合凝膠。該公司正在探索將該技術應用於更廣泛的軟組織修複和再生市場。Celleration總部位於美國明尼蘇達州伊甸草原。Celleration公司。 Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News
Celleration常見問題
Celleration是什麼時候成立的?
Celleration成立於1999年。
Celleration的總部在哪裏?
Celleration公司總部位於伊甸草原Bury Drive 6321號。
Celleration的最新一輪融資是什麼?
Celleration的最新一輪融資是收購。
Celleration籌集了多少資金?
Celleration總共籌集了7385萬美元。
Celleration的投資人是誰?
Celleration的投資者包括Adynxx, Venture Investors, Baird Venture Partners, New Science Ventures, AAVIN等14家公司。
Celleration的競爭對手是誰?
Celleration的競爭對手包括SetPoint Medical、ALung Technologies、AlterG、Promedtek、Acelity等12家公司。
比較Celleration和競爭對手
Insense Ltd開發了一個以原位纏繞氧化為特征的技術平台,並獲得了專利。其首批產品Oxyzyme和Iodozyme針對慢性傷口,並將進入專業醫療保健市場。
SetPoint Medical開發了一種生物電子醫學平台,使用一種小型植入設備,激活人體的自然炎症反射,並產生全身抗炎作用。它旨在治療患有慢性自身免疫性疾病的患者,並為類風濕關節炎、炎症性腸病和其他慢性自身免疫性疾病提供一種治療選擇。該公司成立於2006年,總部位於加利福尼亞州的聖塔克拉利塔。
Perfuzia Medical正在開發用於治療慢性傷口的下一代醫療設備。
創傷科技公司提供了一種專利的非侵入性設備來冷卻大腦
相關性為服務不足的人群提供了一種低風險的治療方法,可以消除背部疼痛,同時保留其他治療方案。該公司的顱內係統是一種微創手術,使用射頻能量通過一個小的通路管進入椎體,消融基底神經。該神經被認為是慢性腰痛的重要原因,在消融後不再產生疼痛信號。該公司成立於2004年,總部位於明尼蘇達州的明尼阿波利斯市。
NeuroTrax是一家醫療設備和技術公司。
為您的團隊發現正確的解決方案
CB I188bet游戏nsights技術市場情報平台分析供應商、產品、合作夥伴和專利的數百萬個數據點,幫助您的團隊找到他們的下一個技術解決方案。